# Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals (AGIO) sees a surge in social media buzz with a 925% increase in social dominance and 266% rise in engagements, driven by anticipation for upcoming Phase 2b trial readouts.

### About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals is a biopharmaceutical company focused on developing therapies for rare genetic diseases and cancer.  
Agios Pharmaceuticals, Inc. uses the ticker $AGIO for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Agios Pharmaceuticals, Inc. (AGIO) social dominance is up 925% from the previous week.
- Agios Pharmaceuticals, Inc. (AGIO) engagements is up 266.12% from the previous week.
- Agios Pharmaceuticals, Inc. (AGIO) posts created is up 380% from the previous week.

### Price: $28
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$agio/time-series/close.tsv)  
The stock price has seen a slight decrease, likely due to mixed Phase [--] trial results for their sickle cell drug. However, a recent uptick in social media sentiment and engagement suggests potential for recovery.  

24-Hour: -0.29%
7-Day: 5.39%
30-Day: 2.83%

1-Year High: $45.50 on 2025-11-18  
1-Year Low: $22.30 on 2025-11-19  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$agio/time-series/alt_rank.tsv)  
Agios Pharmaceuticals, Inc. (AGIO) is currently AltRank #1,731 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +6  
[--] Month: [-----] +689  
[--] Months: [-----] +836  
[--] Year: [-----] +360  
1-Year High: [-----] on 2026-02-04  
1-Year Low: [--] on 2025-12-20  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$agio/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +21  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-06-26  
1-Year Low: [--] on 2025-08-28  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$agio/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +266%  
[--] Month: [-------] -59%  
[--] Months: [---------] +213%  
[--] Year: [---------] -33%  
1-Year High: [-------] on 2025-11-19  
1-Year Low: [--] on 2025-04-20  

Engagements by network (24h):
Reddit: [--]
X: [-----]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$agio/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] -7.30%  
[--] Month: [---] -45%  
[--] Months: [-----] +36%  
[--] Year: [-----] -32%  
1-Year High: [---] on 2025-11-26  
1-Year Low: [--] on 2025-04-19  

Mentions by network (24h):
Reddit: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$agio/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Agios Pharmaceuticals, Inc. (AGIO) in the last [--] hours which is down 41% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -10%  
[--] Month: [---] -52%  
[--] Months: [---] -14%  
[--] Year: [-----] +116%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-22  

The most influential creators that mention Agios Pharmaceuticals, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [-----]       |
| [@SeanValenc89161](/creator/twitter/SeanValenc89161) | [--]    | [---]       | [--]     | [--]          |
| [@Jamce1182025](/creator/twitter/Jamce1182025)       | [--]    | [--]        | [--]     | [--]          |
| [@seedytx19](/creator/twitter/seedytx19)             | [--]    | [-----]     | [--]     | [--]           |
| [@booooogy01](/creator/twitter/booooogy01)           | [--]    | [--]        | [--]     | [--]           |

[View More](/list/creators/$agio/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$agio/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 75%  
[--] Week: 100% no change  
[--] Month: 83% +16%  
[--] Months: 83% +3%  
[--] Year: 83% -4%  
1-Year High: 100% on 2025-02-22  
1-Year Low: 12% on 2025-09-08  

Most Supportive Themes:
- Biotech Stock Catalyst Watchlist: (90%) Focuses on upcoming Phase [--] and Phase [--] clinical trial readouts for various biotechnology stocks.
  
Most Critical Themes:
- Sickle Cell Drug Trial Results: (10%) Mixed Phase [--] trial results for Agios' sickle cell drug are impacting the stock price.
  
  
  
### Social Dominance: 0.00277%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$agio/time-series/social_dominance.tsv)  
Current Value: 0.00277%  
Daily Average: 0.00845%  
[--] Week: 0.0041% +0.0037%  
[--] Month: 0.0059% +0.0007000000000000001%  
[--] Months: 0.0059% -0.0008999999999999998%  
[--] Year: 0.0059% -0.0039%  
1-Year High: 0.052% on 2025-11-26  
1-Year Low: 0.0016% on 2026-02-07  
  
  
### Market Dominance: 0.00185%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$agio/time-series/market_dominance.tsv)  
Current Value: 0.00185%  
Daily Average: 0%  
1-Year High: 0.085% on 2025-11-18  
1-Year Low: 0.00185% on 2026-02-14  
  
  
### Market Cap: $1,632,203,598
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$agio/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$agio/time-series/market_cap.tsv)  
Current Value: $1,632,203,598  
Daily Average: $1,930,552,262  
[--] Week: $1,639,994,894 +5.70%  
[--] Month: $1,638,237,129 +1.10%  
[--] Months: $1,638,237,129 -25%  
[--] Year: $1,638,237,129 -14%  
1-Year High: $2,652,695,308 on 2025-11-18  
1-Year Low: $1,302,730,560 on 2025-11-19  

### Top Agios Pharmaceuticals, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"🧬 Biopharma Weekly Recap 📝 This week in biotech: $NKTR AtD data and financing ignite upside debate GLP-1 pill surge boosts $NVO/$LLY M&A chatter builds and dense Q1 readouts drive volatility. See interesting posts/ppl to check out 👇 @AppleHelix 1/ There is some confusion with the reporting on $MRNA Refuse to File. @seedy19tron The Weekly 🌱 New: $anl $tern $cmps Increased: $abvx $nktr Unchanged: $nxtc $ovid $slno $cntx $pasg $dawn $lqda $rytm Decreased: Closed: $crvs (s) $apge (s) $asnd $ptn $cogt @Andre_AGTC My watch list near term catalysts @ResearchPulse1 Can UBT251 from NVO be a"  
[X Link](https://x.com/BiopharmIQ/status/2022703288546922772) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-14T16:03Z 28.9K followers, [----] engagements


"#earnings before the open on Thursday February [--] [----] $NBIS $MLCO $HWM $BN $ZBRA $CROX $ZTS $BIRK $TU $PCG $QSR $BAX $AEP $AVNT $CHKP $BUD $H $HIMX $TRIP $VNT $IPGP $IRDM $LECO $KELYA $TRN $SPHR $STNG $TNET $PODC $DBD $EEFT $ETR $ABEV $BRKR $AGIO $ALNY $BDC $BGC $AMG $BTDR $CMRC $CNDT $CNR $EXC $FMCC $FTS $GEO $GTES $GVA $CBRE https://www.earningswhispers.com/calendar The most anticipated earnings releases for the week of February [--] [----] are @RobinhoodApp $HOOD @AppLovin $APP @coinbase $COIN @AsteraLabs $ALAB @nebiusai #NBIS @Shopify $SHOP @Vertiv $VRT @Pinterest $PINS @AristaNetworks $ANET"  
[X Link](https://x.com/eWhispers/status/2021669772614877361) [@eWhispers](/creator/x/eWhispers) 2026-02-11T19:36Z 551.6K followers, 47.6K engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"  
[X Link](https://x.com/BiopharmIQ/status/2020573160345940394) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-08T18:59Z 28.9K followers, [----] engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $KOD Phase 2b $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $BFRI Phase [--] $KPTI Phase [--] $IOVA Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $MLTX Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $ARQT"  
[X Link](https://x.com/BiopharmIQ/status/2018051066605220000) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-01T19:57Z 28.9K followers, 112.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing